Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma

• Conditions: Diffuse Large B Cell Lymphoma

• Registration Number: NCT04423549
• Lead Sponsor: Sun Yat-sen University

Brief Summary

The purpose of this study is to determine the predictive value of a mRNA signature and liquid biopsy in patients with Diffuse Large B cell lymphoma.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-06
• Study Start: 2020-06
• Study First Submitted: 2020-06-07
• Study First Submitted QC: 2020-06-07
• Last Update Submitted: 2020-06-07
• Study First Posted: 2020-06-09
• Last Update Posted: 2020-06-09
• Primary Completion: 2021-06
• Study Completion: 2021-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

• biopsy proved Diffuse Large B cell Lymphoma
• newly diagnosed between 2000-01 and 2015-12

Exclusion Criteria

• patients with biopsy samples unavailable

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival	5-years

Trial Locations

Locations (1)

Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University,; 🇨🇳 Guangzhou, China